Keratin Mutation Predisposes to Mouse Liver Fibrosis and Unmasks Differential Effects of the Carbon Tetrachloride and Thioacetamide Models

Gastroenterology

Volumn 134, Issue 4, 2008, Pages 1169-1179

  Strnad, Pavel ^a   Tao, Guo Zhong ^a   Zhou, Qin ^a   Harada, Masaru ^b   Toivola, Diana M ^a   Brunt, Elizabeth M ^c   Omary, M Bishr ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON TETRACHLORIDE; COLLAGEN; COLLAGENASE 3; CYTOKERATIN 18; CYTOKERATIN 9; GELATINASE A; HYDROXYPROLINE; KERATIN; THIOACETAMIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE INDUCTION; GENE MUTATION; GENE OVEREXPRESSION; HISTOPATHOLOGY; IMMUNOFLUORESCENCE TEST; LIVER CIRRHOSIS; LIVER FIBROSIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 41349120465     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.01.035     Document Type: Article

References (63)

1. Ku N.O., Zhou X., Toivola D.M., et al. The cytoskeleton of digestive epithelia in health and disease. Am J Physiol 277 (1999) G1108-G1137
2. Omary M.B., Coulombe P.A., and McLean W.H. Intermediate filament proteins and their associated diseases. N Engl J Med 351 (2004) 2087-2100
3. Herrmann H., Hesse M., Reichenzeller M., et al. Functional complexity of intermediate filament cytoskeletons: from structure to assembly to gene ablation. Int Rev Cytol 223 (2003) 83-175
4. Coulombe P.A., and Wong P. Cytoplasmic intermediate filaments revealed as dynamic and multipurpose scaffolds. Nat Cell Biol 6 (2004) 699-706
5. Worman H.J., and Courvalin J.C. Nuclear envelope, nuclear lamina, and inherited disease. Int Rev Cytol 246 (2005) 231-279
6. Mattout A., Dechat T., Adam S.A., et al. Nuclear lamins, diseases and aging. Curr Opin Cell Biol 18 (2006) 335-341
7. Coulombe P.A., and Omary M.B. "Hard" and "soft" principles defining the structure, function and regulation of keratin intermediate filaments. Curr Opin Cell Biol 14 (2002) 110-122
8. Schweizer J., Bowden P.E., Coulombe P.A., et al. New consensus nomenclature for mammalian keratins. J Cell Biol 174 (2006) 169-174
9. Quinlan R.A., Cohlberg J.A., Schiller D.L., et al. Heterotypic tetramer (A2D2) complexes of non-epidermal keratins isolated from cytoskeletons of rat hepatocytes and hepatoma cells. J Mol Biol 178 (1984) 365-388
10. Kulesh D.A., Cecena G., Darmon Y.M., et al. Posttranslational regulation of keratins: degradation of mouse and human keratins 18 and 8. Mol Cell Biol 9 (1989) 1553-1565
11. Ku N.O., and Omary M.B. Keratins turn over by ubiquitination in a phosphorylation-modulated fashion. J Cell Biol 149 (2000) 547-552
12. Zhou Q., Toivola D.M., Feng N., et al. Keratin 20 helps maintain intermediate filament organization in intestinal epithelia. Mol Biol Cell 14 (2003) 2959-2971
13. Helfand B.T., Chang L., and Goldman R.D. Intermediate filaments are dynamic and motile elements of cellular architecture. J Cell Sci 117 (2004) 133-141
14. Magin T.M., Vijayaraj P., and Leube R.E. Structural and regulatory functions of keratins. Exp Cell Res 313 (2007) 2021-2032
15. Omary M.B., Ku N.O., Tao G.Z., et al. "Heads and tails" of intermediate filament phosphorylation: multiple sites and functional insights. Trends Biochem Sci 31 (2006) 383-394
16. Green K.J., Bohringer M., Gocken T., et al. Intermediate filament associated proteins. Adv Protein Chem 70 (2005) 143-202
17. Toivola D.M., Ku N.O., Resurreccion E.Z., et al. Keratin 8 and 18 hyperphosphorylation is a marker of progression of human liver disease. Hepatology 40 (2004) 459-466
18. Ku N.O., Strnad P., Zhong B., et al. Keratins let liver live: mutations predispose to liver disease and crosslinking generates Mallory-Denk bodies. Hepatology 46 (2007) 1639-1649
19. Ku N.O., Michie S.A., Soetikno R.M., et al. Susceptibility to hepatotoxicity in transgenic mice that express a dominant-negative human keratin 18 mutant. J Clin Invest 98 (1996) 1034-1046
20. Ku N.O., Soetikno R.M., and Omary M.B. Keratin mutation in transgenic mice predisposes to FAS but not TNF induced apoptosis and massive liver injury. Hepatology 37 (2003) 1006-1014
21. Porter R.M., and Lane E.B. Phenotypes, genotypes and their contribution to understanding keratin function. Trends Genet 19 (2003) 278-285
22. Ku N.O., Gish R., Wright T.L., et al. Keratin 8 mutations in patients with cryptogenic liver disease. N Engl J Med 344 (2001) 1580-1587
23. Ku N.O., Lim J.K., Krams S.M., et al. Keratins as susceptibility genes for end-stage liver disease. Gastroenterology 129 (2005) 885-893
24. Strnad P., Lienau T.C., Tao G.Z., et al. Keratin variants associate with progression of fibrosis during chronic hepatitis C infection. Hepatology 43 (2006) 1354-1363
25. Krahenbuhl S., and Reichen J. Adaptation of mitochondrial metabolism in liver cirrhosis. Different strategies to maintain a vital function. Scand J Gastroenterol 193 (1992) 90-96
26. Weber L.W., Boll M., and Stampfl A. Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit Rev Toxicol 33 (2003) 105-136
27. Tsukamoto H., Matsuoka M., and French S.W. Experimental models of hepatic fibrosis: a review. Semin Liver Dis 10 (1990) 56-65
28. Constandinou C., Henderson N., and Iredale J.P. Modeling liver fibrosis in rodents. Methods Mol Med 117 (2005) 237-250
29. Ku N.O., Michie S., Oshima R.G., et al. Chronic hepatitis, hepatocyte fragility, and increased soluble phosphoglycokeratins in transgenic mice expressing a keratin 18 conserved arginine mutant. J Cell Biol 131 (1995) 1303-1314
30. Harada M., Strnad P., Resurreccion E., et al. Keratin 18 overexpression but not phosphorylation or filament organization blocks mouse Mallory body formation. Hepatology 45 (2007) 88-96
31. Ku N.O., Michie S.A., Soetikno R.M., et al. Mutation of a major keratin phosphorylation site predisposes to hepatotoxic injury in transgenic mice. J Cell Biol 143 (1998) 2023-2032
32. Ku N.O., Toivola D.M., Zhou Q., et al. Studying simple epithelial keratins in cells and tissues. Methods Cell Biol 8 (2004) 489-517
33. Bernstein E.F., Fisher L.W., Li K., et al. Differential expression of the versican and decorin genes in photoaged and sun-protected skin. Comparison by immunohistochemical and northern analyses. Lab Invest 72 (1995) 662-669
34. Scheuer P.J. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 13 (1991) 372-374
35. Nakamichi I., Toivola D.M., Strnad P., et al. Keratin 8 overexpression promotes mouse Mallory body formation. J Cell Biol 171 (2005) 931-937
36. Edwards C.A., and O'Brien Jr. W.D. Modified assay for determination of hydroxyproline in a tissue hydrolyzate. Clin Chim Acta 104 (1980) 161-167
37. Xia J.L., Dai C., Michalopoulos G.K., et al. Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation. Am J Pathol 168 (2006) 1500-1512
38. Shi Z., Wakil A.E., and Rockey D.C. Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses. Proc Natl Acad Sci U S A 94 (1997) 10663-10668
39. Zatloukal K., French S.W., Stumptner C., et al. From Mallory to Mallory-Denk bodies: what, how and why?. Exp Cell Res 313 (2007) 2033-2049
40. Tao G.Z., Toivola D.M., Zhong B., et al. Keratin-8 null mice have different gallbladder and liver susceptibility to lithogenic diet-induced injury. J Cell Sci 116 (2003) 4629-4638
41. Sonnenberg A., and Liem R.K. Plakins in development and disease. Exp Cell Res 313 (2007) 2189-2203
42. Liao J., Lowthert L.A., Ghori N., et al. The 70-kDa heat shock proteins associate with glandular intermediate filaments in an ATP-dependent manner. J Biol Chem 270 (1995) 915-922
43. Zatloukal K., Stumptner C., Fuchsbichler A., et al. The keratin cytoskeleton in liver diseases. J Pathol 204 (2004) 367-376
44. Ku N.O., and Omary M.B. A disease- and phosphorylation-related nonmechanical function for keratin 8. J Cell Biol 174 (2006) 115-125
45. Owens D.W., Wilson N.J., Hill A.J., et al. Human keratin 8 mutations that disturb filament assembly observed in inflammatory bowel disease patients. J Cell Sci 117 (2004) 1989-1999
46. Friedman S.L. Mechanisms of disease: mechanisms of hepatic fibrosis and therapeutic implications. Nat Clin Pract Gastroenterol Hepatol 1 (2004) 98-105
47. Iredale J.P. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest 117 (2007) 539-548
48. Zhong B., Zhou Q., Toivola D.M., et al. Organ-specific stress induces mouse pancreatic keratin overexpression in association with NF-kappaB activation. J Cell Sci 117 (2004) 1709-1719
49. Tao G.Z., Zhou Q., Strnad P., et al. Human Ran cysteine-112 oxidation by pervanadate regulates its binding to keratins. J Biol Chem 280 (2005) 12162-12167
50. Zhou Q., Ji X., Chen L., et al. Keratin mutation primes mouse liver to oxidative injury. Hepatology 41 (2005) 517-525
51. Siegmund S.V., Dooley S., and Brenner D.A. Molecular mechanisms of alcohol-induced hepatic fibrosis. Dig Dis 23 (2005) 264-274
52. Farrell G.C., and Larter C.Z. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43 (2006) S99-S112
53. Natarajan S.K., Thomas S., Ramamoorthy P., et al. Oxidative stress in the development of liver cirrhosis: a comparison of two different experimental models. J Gastroenterol Hepatol 21 (2006) 947-957
54. Caulin C., Ware C.F., Magin T.M., et al. Keratin-dependent, epithelial resistance to tumor necrosis factor-induced apoptosis. J Cell Biol 149 (2000) 17-22
55. Gilbert S., Loranger A., Daigle N., et al. Simple epithelial keratins 8 and 18 provide resistance to Fas-mediated apoptosis. The protection occurs through a receptor-targeting modulation. J Cell Biol 154 (2001) 763-773
56. Takehara T., Tatsumi T., Suzuki T., et al. Hepatocyte-specific disruption of Bcl-xL leads to continuous hepatocyte apoptosis and liver fibrotic responses. Gastroenterology 127 (2004) 1189-1197
57. Dyroff M.C., and Neal R.A. Identification of the major protein adduct formed in rat liver after thioacetamide administration. Cancer Res 41 (1981) 3430-3435
58. Bulera S.J., Eddy S.M., Ferguson E., et al. RNA expression in the early characterization of hepatotoxicants in Wistar rats by high-density DNA microarrays. Hepatology 33 (2001) 1239-1258
59. Jeong D.H., Jang J.J., Lee S.J., et al. Expression patterns of cell cycle-related proteins in a rat cirrhotic model induced by CCl4 or thioacetamide. J Gastroenterol 36 (2001) 24-32
60. Guyot C., Combe C., Clouzeau-Girard H., et al. Specific activation of the different fibrogenic cells in rat cultured liver slices mimicking in vivo situations. Virchows Arch 450 (2007) 503-512
61. Shi Z., Wakil A.E., and Rockey D.C. Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses. Proc Natl Acad Sci U S A 94 (1997) 10663-10668
62. Perng M.D., Cairns L., van den Ijssel P., et al. Intermediate filament interactions can be altered by HSP27 and alphaB-crystallin. J Cell Sci 112 (1999) 2099-2112
63. Feldstein A.E., Canbay A., Angulo P., et al. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 125 (2003) 437-443